Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-week randomized open-label comparison of telbivudine versus entecavir in HBeAg-positive chronic hepatitis B
ChiCTR-TRC-09000341Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Oct 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Chronic Hepatitis B (CHB) comparing Telbivudine Group with Entecavir Group (2 arms). Primary endpoints: HBV-DNA, HBV markers and 1 more. Started Oct 2008; status: completed.
02
Drugs
telbivudineentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-09000341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000341.